Trivoglicad 1 mg/500 mg/0.3 mg Tablet
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Primary uses of : Type 2 diabetes
-
-
-
*
-
|
Composition
|
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg) |
|
Potentially Unsafe With
|
Alcohol |
|
Side Effect
|
Common
Side Effects of Trivoglicad are Hypoglycemia (low blood sugar level), Nausea, Diarrhoea, Altered taste, Flatulence, Stomach pain, Headache, Skin rash, Respiratory tract infection. |
|
How to works
|
How Trivoglicad Tablet works
Trivoglicad 1 mg/500 mg/0.3 mg Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals. |
